Detail Information of Epigenetic Regulations
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0168 Transporter Info | ||||
Gene Name | SLC25A10 | ||||
Transporter Name | Mitochondrial dicarboxylate carrier | ||||
Gene ID | |||||
UniProt ID | |||||
Epigenetic Regulations of This DT (EGR) | |||||
---|---|---|---|---|---|
Methylation |
|||||
Colon cancer |
8 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC25A10 in colon adenocarcinoma | [ 1 ] | |||
Location |
5'UTR (cg16313393) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.48E+00 | Statistic Test | p-value: 9.07E-08; Z-score: -3.59E+00 | ||
Methylation in Case |
3.73E-01 (Median) | Methylation in Control | 5.52E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC25A10 in colon adenocarcinoma | [ 1 ] | |||
Location |
TSS200 (cg11960629) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 3.17E+00 | Statistic Test | p-value: 1.36E-08; Z-score: 6.36E+00 | ||
Methylation in Case |
5.55E-01 (Median) | Methylation in Control | 1.75E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC25A10 in colon adenocarcinoma | [ 1 ] | |||
Location |
Body (cg18101022) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 2.19E+00 | Statistic Test | p-value: 6.86E-08; Z-score: 3.92E+00 | ||
Methylation in Case |
5.17E-01 (Median) | Methylation in Control | 2.37E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC25A10 in colon adenocarcinoma | [ 1 ] | |||
Location |
Body (cg16997104) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.11E+00 | Statistic Test | p-value: 1.43E-07; Z-score: 3.02E+00 | ||
Methylation in Case |
8.88E-01 (Median) | Methylation in Control | 8.03E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC25A10 in colon adenocarcinoma | [ 1 ] | |||
Location |
Body (cg09173378) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.23E+00 | Statistic Test | p-value: 5.13E-06; Z-score: -1.55E+00 | ||
Methylation in Case |
4.57E-01 (Median) | Methylation in Control | 5.62E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC25A10 in colon adenocarcinoma | [ 1 ] | |||
Location |
Body (cg17206420) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.20E+00 | Statistic Test | p-value: 2.57E-05; Z-score: -1.58E+00 | ||
Methylation in Case |
3.41E-01 (Median) | Methylation in Control | 4.08E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC25A10 in colon adenocarcinoma | [ 1 ] | |||
Location |
Body (cg05030251) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.17E+00 | Statistic Test | p-value: 1.09E-03; Z-score: -2.39E+00 | ||
Methylation in Case |
6.42E-01 (Median) | Methylation in Control | 7.49E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of SLC25A10 in colon adenocarcinoma | [ 1 ] | |||
Location |
Body (cg10701282) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 3.14E+00 | Statistic Test | p-value: 1.45E-03; Z-score: 6.49E+00 | ||
Methylation in Case |
1.49E-01 (Median) | Methylation in Control | 4.76E-02 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Hepatocellular carcinoma |
13 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC25A10 in hepatocellular carcinoma | [ 2 ] | |||
Location |
5'UTR (cg20277159) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.47E+00 | Statistic Test | p-value: 1.01E-17; Z-score: -4.53E+00 | ||
Methylation in Case |
5.06E-01 (Median) | Methylation in Control | 7.42E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC25A10 in hepatocellular carcinoma | [ 2 ] | |||
Location |
Body (cg06173579) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.49E+00 | Statistic Test | p-value: 2.02E-18; Z-score: -4.56E+00 | ||
Methylation in Case |
5.37E-01 (Median) | Methylation in Control | 7.98E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC25A10 in hepatocellular carcinoma | [ 2 ] | |||
Location |
Body (cg20998200) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.41E+00 | Statistic Test | p-value: 1.75E-15; Z-score: -2.37E+00 | ||
Methylation in Case |
3.26E-01 (Median) | Methylation in Control | 4.61E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC25A10 in hepatocellular carcinoma | [ 2 ] | |||
Location |
Body (cg01550915) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.33E+00 | Statistic Test | p-value: 2.16E-10; Z-score: -2.36E+00 | ||
Methylation in Case |
6.24E-01 (Median) | Methylation in Control | 8.31E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC25A10 in hepatocellular carcinoma | [ 2 ] | |||
Location |
Body (cg13150534) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.29E+00 | Statistic Test | p-value: 1.81E-09; Z-score: -1.41E+00 | ||
Methylation in Case |
3.60E-01 (Median) | Methylation in Control | 4.65E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC25A10 in hepatocellular carcinoma | [ 2 ] | |||
Location |
Body (cg09996840) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.22E+00 | Statistic Test | p-value: 1.36E-08; Z-score: -1.38E+00 | ||
Methylation in Case |
4.17E-01 (Median) | Methylation in Control | 5.09E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC25A10 in hepatocellular carcinoma | [ 2 ] | |||
Location |
Body (cg17913115) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.35E+00 | Statistic Test | p-value: 5.48E-08; Z-score: -1.27E+00 | ||
Methylation in Case |
3.02E-01 (Median) | Methylation in Control | 4.06E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of SLC25A10 in hepatocellular carcinoma | [ 2 ] | |||
Location |
Body (cg13117272) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.27E+00 | Statistic Test | p-value: 3.55E-07; Z-score: -1.36E+00 | ||
Methylation in Case |
3.30E-01 (Median) | Methylation in Control | 4.18E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 9 |
Methylation of SLC25A10 in hepatocellular carcinoma | [ 2 ] | |||
Location |
Body (cg10460003) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.10E+00 | Statistic Test | p-value: 9.47E-07; Z-score: -1.23E+00 | ||
Methylation in Case |
7.84E-01 (Median) | Methylation in Control | 8.61E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 10 |
Methylation of SLC25A10 in hepatocellular carcinoma | [ 2 ] | |||
Location |
Body (cg08120644) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 3.52E-04; Z-score: -3.57E-01 | ||
Methylation in Case |
8.65E-01 (Median) | Methylation in Control | 8.72E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 11 |
Methylation of SLC25A10 in hepatocellular carcinoma | [ 2 ] | |||
Location |
Body (cg05485968) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.07E+00 | Statistic Test | p-value: 1.15E-03; Z-score: -5.41E-01 | ||
Methylation in Case |
7.27E-01 (Median) | Methylation in Control | 7.75E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 12 |
Methylation of SLC25A10 in hepatocellular carcinoma | [ 2 ] | |||
Location |
Body (cg14852540) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 5.92E-03; Z-score: -4.67E-01 | ||
Methylation in Case |
8.33E-01 (Median) | Methylation in Control | 8.40E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 13 |
Methylation of SLC25A10 in hepatocellular carcinoma | [ 2 ] | |||
Location |
Body (cg25742382) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 2.83E-02; Z-score: -4.60E-01 | ||
Methylation in Case |
9.04E-01 (Median) | Methylation in Control | 9.11E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Bladder cancer |
13 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC25A10 in bladder cancer | [ 3 ] | |||
Location |
TSS1500 (cg14062197) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.18E+00 | Statistic Test | p-value: 1.17E-03; Z-score: -2.06E+00 | ||
Methylation in Case |
6.76E-02 (Median) | Methylation in Control | 7.97E-02 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC25A10 in bladder cancer | [ 3 ] | |||
Location |
TSS1500 (cg11969191) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.22E+00 | Statistic Test | p-value: 1.70E-02; Z-score: -1.47E+00 | ||
Methylation in Case |
9.70E-02 (Median) | Methylation in Control | 1.18E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC25A10 in bladder cancer | [ 3 ] | |||
Location |
TSS1500 (cg02067430) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.47E+00 | Statistic Test | p-value: 2.05E-02; Z-score: -1.81E+00 | ||
Methylation in Case |
5.07E-02 (Median) | Methylation in Control | 7.44E-02 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC25A10 in bladder cancer | [ 3 ] | |||
Location |
1stExon (cg10299667) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.13E+00 | Statistic Test | p-value: 2.39E-02; Z-score: -8.79E-01 | ||
Methylation in Case |
6.00E-02 (Median) | Methylation in Control | 6.80E-02 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC25A10 in bladder cancer | [ 3 ] | |||
Location |
Body (cg13150534) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.75E+00 | Statistic Test | p-value: 4.90E-10; Z-score: -8.87E+00 | ||
Methylation in Case |
2.97E-01 (Median) | Methylation in Control | 5.20E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC25A10 in bladder cancer | [ 3 ] | |||
Location |
Body (cg09996840) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.71E+00 | Statistic Test | p-value: 2.24E-09; Z-score: -7.82E+00 | ||
Methylation in Case |
3.55E-01 (Median) | Methylation in Control | 6.09E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC25A10 in bladder cancer | [ 3 ] | |||
Location |
Body (cg10460003) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.08E+00 | Statistic Test | p-value: 1.12E-05; Z-score: -5.68E+00 | ||
Methylation in Case |
8.24E-01 (Median) | Methylation in Control | 8.91E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of SLC25A10 in bladder cancer | [ 3 ] | |||
Location |
Body (cg17913115) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -2.26E+00 | Statistic Test | p-value: 2.26E-05; Z-score: -4.92E+00 | ||
Methylation in Case |
1.77E-01 (Median) | Methylation in Control | 4.01E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 9 |
Methylation of SLC25A10 in bladder cancer | [ 3 ] | |||
Location |
Body (cg13117272) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.39E+00 | Statistic Test | p-value: 4.54E-05; Z-score: -3.87E+00 | ||
Methylation in Case |
3.83E-01 (Median) | Methylation in Control | 5.33E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 10 |
Methylation of SLC25A10 in bladder cancer | [ 3 ] | |||
Location |
Body (cg05485968) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.03E+00 | Statistic Test | p-value: 1.63E-02; Z-score: -2.24E+00 | ||
Methylation in Case |
8.51E-01 (Median) | Methylation in Control | 8.72E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 11 |
Methylation of SLC25A10 in bladder cancer | [ 3 ] | |||
Location |
Body (cg18517517) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.02E+00 | Statistic Test | p-value: 2.69E-02; Z-score: -9.21E-01 | ||
Methylation in Case |
7.65E-01 (Median) | Methylation in Control | 7.77E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 12 |
Methylation of SLC25A10 in bladder cancer | [ 3 ] | |||
Location |
Body (cg25742382) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.02E+00 | Statistic Test | p-value: 4.65E-02; Z-score: -1.33E+00 | ||
Methylation in Case |
8.59E-01 (Median) | Methylation in Control | 8.77E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 13 |
Methylation of SLC25A10 in bladder cancer | [ 3 ] | |||
Location |
3'UTR (cg06380072) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.08E+00 | Statistic Test | p-value: 9.59E-03; Z-score: 1.50E+00 | ||
Methylation in Case |
8.90E-01 (Median) | Methylation in Control | 8.28E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Breast cancer |
10 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC25A10 in breast cancer | [ 4 ] | |||
Location |
TSS1500 (cg07845392) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.31E+00 | Statistic Test | p-value: 7.27E-14; Z-score: 2.92E+00 | ||
Methylation in Case |
4.43E-01 (Median) | Methylation in Control | 3.39E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC25A10 in breast cancer | [ 4 ] | |||
Location |
TSS1500 (cg11969191) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.12E+00 | Statistic Test | p-value: 2.15E-03; Z-score: -4.59E-01 | ||
Methylation in Case |
7.92E-02 (Median) | Methylation in Control | 8.89E-02 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC25A10 in breast cancer | [ 4 ] | |||
Location |
Body (cg27059552) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.11E+00 | Statistic Test | p-value: 2.10E-06; Z-score: 1.12E+00 | ||
Methylation in Case |
8.56E-01 (Median) | Methylation in Control | 7.68E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC25A10 in breast cancer | [ 4 ] | |||
Location |
Body (cg17913115) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.52E+00 | Statistic Test | p-value: 1.10E-05; Z-score: 1.80E+00 | ||
Methylation in Case |
3.81E-01 (Median) | Methylation in Control | 2.51E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC25A10 in breast cancer | [ 4 ] | |||
Location |
Body (cg13117272) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.17E+00 | Statistic Test | p-value: 2.01E-05; Z-score: -1.40E+00 | ||
Methylation in Case |
4.69E-01 (Median) | Methylation in Control | 5.49E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC25A10 in breast cancer | [ 4 ] | |||
Location |
Body (cg05485968) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.03E+00 | Statistic Test | p-value: 4.88E-05; Z-score: -9.60E-01 | ||
Methylation in Case |
8.36E-01 (Median) | Methylation in Control | 8.59E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC25A10 in breast cancer | [ 4 ] | |||
Location |
Body (cg09996840) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.18E+00 | Statistic Test | p-value: 5.74E-04; Z-score: -1.01E+00 | ||
Methylation in Case |
4.53E-01 (Median) | Methylation in Control | 5.33E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of SLC25A10 in breast cancer | [ 4 ] | |||
Location |
Body (cg06555404) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.09E+00 | Statistic Test | p-value: 6.51E-04; Z-score: 8.66E-01 | ||
Methylation in Case |
8.59E-01 (Median) | Methylation in Control | 7.88E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 9 |
Methylation of SLC25A10 in breast cancer | [ 4 ] | |||
Location |
Body (cg13150534) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.06E+00 | Statistic Test | p-value: 1.08E-03; Z-score: -6.92E-01 | ||
Methylation in Case |
4.88E-01 (Median) | Methylation in Control | 5.19E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 10 |
Methylation of SLC25A10 in breast cancer | [ 4 ] | |||
Location |
3'UTR (cg08367465) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.07E+00 | Statistic Test | p-value: 5.68E-08; Z-score: 1.61E+00 | ||
Methylation in Case |
7.74E-01 (Median) | Methylation in Control | 7.25E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Renal cell carcinoma |
8 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC25A10 in clear cell renal cell carcinoma | [ 5 ] | |||
Location |
TSS1500 (cg07845392) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.36E+00 | Statistic Test | p-value: 7.08E-09; Z-score: 2.20E+00 | ||
Methylation in Case |
4.54E-01 (Median) | Methylation in Control | 3.33E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC25A10 in clear cell renal cell carcinoma | [ 5 ] | |||
Location |
TSS1500 (cg14062197) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.17E+00 | Statistic Test | p-value: 9.54E-03; Z-score: 6.06E-01 | ||
Methylation in Case |
2.36E-02 (Median) | Methylation in Control | 2.03E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC25A10 in clear cell renal cell carcinoma | [ 5 ] | |||
Location |
Body (cg22481974) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.04E+00 | Statistic Test | p-value: 1.35E-11; Z-score: 1.10E+00 | ||
Methylation in Case |
9.58E-01 (Median) | Methylation in Control | 9.22E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC25A10 in clear cell renal cell carcinoma | [ 5 ] | |||
Location |
Body (cg11609462) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.06E+00 | Statistic Test | p-value: 1.02E-09; Z-score: 1.33E+00 | ||
Methylation in Case |
9.30E-01 (Median) | Methylation in Control | 8.76E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC25A10 in clear cell renal cell carcinoma | [ 5 ] | |||
Location |
Body (cg03372654) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.02E+00 | Statistic Test | p-value: 2.54E-09; Z-score: 9.72E-01 | ||
Methylation in Case |
9.78E-01 (Median) | Methylation in Control | 9.58E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC25A10 in clear cell renal cell carcinoma | [ 5 ] | |||
Location |
Body (cg25499573) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.01E+00 | Statistic Test | p-value: 6.44E-06; Z-score: 4.11E-01 | ||
Methylation in Case |
9.80E-01 (Median) | Methylation in Control | 9.73E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC25A10 in clear cell renal cell carcinoma | [ 5 ] | |||
Location |
Body (cg17913115) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.53E+00 | Statistic Test | p-value: 6.86E-05; Z-score: 1.41E+00 | ||
Methylation in Case |
3.61E-01 (Median) | Methylation in Control | 2.36E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of SLC25A10 in clear cell renal cell carcinoma | [ 5 ] | |||
Location |
Body (cg18517517) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 7.05E-03; Z-score: -5.47E-01 | ||
Methylation in Case |
8.80E-01 (Median) | Methylation in Control | 8.88E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Colorectal cancer |
5 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC25A10 in colorectal cancer | [ 6 ] | |||
Location |
TSS1500 (cg14062197) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.18E+00 | Statistic Test | p-value: 3.33E-04; Z-score: 1.20E+00 | ||
Methylation in Case |
8.71E-02 (Median) | Methylation in Control | 7.38E-02 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC25A10 in colorectal cancer | [ 6 ] | |||
Location |
Body (cg14852540) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.00E+00 | Statistic Test | p-value: 2.66E-03; Z-score: -3.12E-01 | ||
Methylation in Case |
9.40E-01 (Median) | Methylation in Control | 9.42E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC25A10 in colorectal cancer | [ 6 ] | |||
Location |
Body (cg22481974) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.00E+00 | Statistic Test | p-value: 7.34E-03; Z-score: -1.91E-01 | ||
Methylation in Case |
9.37E-01 (Median) | Methylation in Control | 9.38E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC25A10 in colorectal cancer | [ 6 ] | |||
Location |
Body (cg27059552) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.00E+00 | Statistic Test | p-value: 1.48E-02; Z-score: -5.77E-01 | ||
Methylation in Case |
9.44E-01 (Median) | Methylation in Control | 9.48E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC25A10 in colorectal cancer | [ 6 ] | |||
Location |
3'UTR (cg08367465) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 3.53E-03; Z-score: -6.02E-01 | ||
Methylation in Case |
8.44E-01 (Median) | Methylation in Control | 8.57E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
HIV infection |
8 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC25A10 in HIV infection | [ 7 ] | |||
Location |
TSS1500 (cg07845392) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.26E+00 | Statistic Test | p-value: 7.43E-08; Z-score: 2.38E+00 | ||
Methylation in Case |
5.35E-01 (Median) | Methylation in Control | 4.25E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC25A10 in HIV infection | [ 7 ] | |||
Location |
Body (cg09996840) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.24E+00 | Statistic Test | p-value: 3.15E-17; Z-score: 4.37E+00 | ||
Methylation in Case |
8.21E-01 (Median) | Methylation in Control | 6.62E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC25A10 in HIV infection | [ 7 ] | |||
Location |
Body (cg13150534) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.07E+00 | Statistic Test | p-value: 4.18E-11; Z-score: 1.63E+00 | ||
Methylation in Case |
8.13E-01 (Median) | Methylation in Control | 7.57E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC25A10 in HIV infection | [ 7 ] | |||
Location |
Body (cg25742382) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.01E+00 | Statistic Test | p-value: 3.90E-03; Z-score: 3.96E-01 | ||
Methylation in Case |
9.23E-01 (Median) | Methylation in Control | 9.17E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC25A10 in HIV infection | [ 7 ] | |||
Location |
Body (cg06555404) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.02E+00 | Statistic Test | p-value: 6.86E-03; Z-score: -8.45E-01 | ||
Methylation in Case |
8.99E-01 (Median) | Methylation in Control | 9.20E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC25A10 in HIV infection | [ 7 ] | |||
Location |
Body (cg11609462) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.03E+00 | Statistic Test | p-value: 1.10E-02; Z-score: 1.00E+00 | ||
Methylation in Case |
8.95E-01 (Median) | Methylation in Control | 8.66E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC25A10 in HIV infection | [ 7 ] | |||
Location |
Body (cg16087482) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 1.29E-02; Z-score: -7.11E-01 | ||
Methylation in Case |
9.74E-01 (Median) | Methylation in Control | 9.81E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of SLC25A10 in HIV infection | [ 7 ] | |||
Location |
3'UTR (cg08367465) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.02E+00 | Statistic Test | p-value: 1.85E-04; Z-score: 8.92E-01 | ||
Methylation in Case |
8.75E-01 (Median) | Methylation in Control | 8.58E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Pancretic ductal adenocarcinoma |
8 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC25A10 in pancretic ductal adenocarcinoma | [ 8 ] | |||
Location |
TSS1500 (cg20662930) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.27E+00 | Statistic Test | p-value: 2.70E-12; Z-score: 1.28E+00 | ||
Methylation in Case |
2.02E-01 (Median) | Methylation in Control | 1.58E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC25A10 in pancretic ductal adenocarcinoma | [ 8 ] | |||
Location |
TSS200 (cg21485906) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.65E+00 | Statistic Test | p-value: 2.70E-09; Z-score: -1.93E+00 | ||
Methylation in Case |
2.63E-01 (Median) | Methylation in Control | 4.35E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC25A10 in pancretic ductal adenocarcinoma | [ 8 ] | |||
Location |
TSS200 (cg16703647) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.02E+00 | Statistic Test | p-value: 1.73E-07; Z-score: 1.05E-01 | ||
Methylation in Case |
1.45E-01 (Median) | Methylation in Control | 1.43E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC25A10 in pancretic ductal adenocarcinoma | [ 8 ] | |||
Location |
1stExon (cg24396691) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.11E+00 | Statistic Test | p-value: 2.17E-04; Z-score: 2.31E-01 | ||
Methylation in Case |
4.70E-02 (Median) | Methylation in Control | 4.25E-02 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC25A10 in pancretic ductal adenocarcinoma | [ 8 ] | |||
Location |
Body (cg13881637) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.26E+00 | Statistic Test | p-value: 1.74E-08; Z-score: 1.62E+00 | ||
Methylation in Case |
3.00E-01 (Median) | Methylation in Control | 2.38E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC25A10 in pancretic ductal adenocarcinoma | [ 8 ] | |||
Location |
Body (cg22328426) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.16E+00 | Statistic Test | p-value: 2.04E-05; Z-score: -1.01E+00 | ||
Methylation in Case |
4.18E-01 (Median) | Methylation in Control | 4.84E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC25A10 in pancretic ductal adenocarcinoma | [ 8 ] | |||
Location |
Body (cg08186671) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.04E+00 | Statistic Test | p-value: 2.77E-05; Z-score: -8.68E-01 | ||
Methylation in Case |
8.29E-01 (Median) | Methylation in Control | 8.60E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of SLC25A10 in pancretic ductal adenocarcinoma | [ 8 ] | |||
Location |
Body (cg09361598) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.03E+00 | Statistic Test | p-value: 7.19E-05; Z-score: 1.05E+00 | ||
Methylation in Case |
7.89E-01 (Median) | Methylation in Control | 7.63E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Papillary thyroid cancer |
12 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC25A10 in papillary thyroid cancer | [ 9 ] | |||
Location |
TSS1500 (cg07845392) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.12E+00 | Statistic Test | p-value: 4.24E-04; Z-score: 9.36E-01 | ||
Methylation in Case |
4.16E-01 (Median) | Methylation in Control | 3.73E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC25A10 in papillary thyroid cancer | [ 9 ] | |||
Location |
TSS1500 (cg02067430) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.04E+00 | Statistic Test | p-value: 1.41E-02; Z-score: -2.81E-01 | ||
Methylation in Case |
6.36E-02 (Median) | Methylation in Control | 6.63E-02 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC25A10 in papillary thyroid cancer | [ 9 ] | |||
Location |
Body (cg27059552) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 2.51E-09; Z-score: -1.33E+00 | ||
Methylation in Case |
9.28E-01 (Median) | Methylation in Control | 9.42E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC25A10 in papillary thyroid cancer | [ 9 ] | |||
Location |
Body (cg13150534) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.21E+00 | Statistic Test | p-value: 5.62E-06; Z-score: -1.51E+00 | ||
Methylation in Case |
5.75E-01 (Median) | Methylation in Control | 6.97E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC25A10 in papillary thyroid cancer | [ 9 ] | |||
Location |
Body (cg06555404) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.02E+00 | Statistic Test | p-value: 6.63E-05; Z-score: -1.21E+00 | ||
Methylation in Case |
9.43E-01 (Median) | Methylation in Control | 9.57E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC25A10 in papillary thyroid cancer | [ 9 ] | |||
Location |
Body (cg11609462) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 1.20E-03; Z-score: -7.41E-01 | ||
Methylation in Case |
9.24E-01 (Median) | Methylation in Control | 9.35E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC25A10 in papillary thyroid cancer | [ 9 ] | |||
Location |
Body (cg13117272) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.06E+00 | Statistic Test | p-value: 1.80E-03; Z-score: -6.11E-01 | ||
Methylation in Case |
6.66E-01 (Median) | Methylation in Control | 7.04E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of SLC25A10 in papillary thyroid cancer | [ 9 ] | |||
Location |
Body (cg08120644) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.01E+00 | Statistic Test | p-value: 8.42E-03; Z-score: 7.30E-01 | ||
Methylation in Case |
9.49E-01 (Median) | Methylation in Control | 9.39E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 9 |
Methylation of SLC25A10 in papillary thyroid cancer | [ 9 ] | |||
Location |
Body (cg09996840) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.10E+00 | Statistic Test | p-value: 9.49E-03; Z-score: -9.16E-01 | ||
Methylation in Case |
5.92E-01 (Median) | Methylation in Control | 6.54E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 10 |
Methylation of SLC25A10 in papillary thyroid cancer | [ 9 ] | |||
Location |
Body (cg00179532) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.01E+00 | Statistic Test | p-value: 1.65E-02; Z-score: 8.20E-01 | ||
Methylation in Case |
9.57E-01 (Median) | Methylation in Control | 9.52E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 11 |
Methylation of SLC25A10 in papillary thyroid cancer | [ 9 ] | |||
Location |
Body (cg14852540) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 1.89E-02; Z-score: -4.02E-01 | ||
Methylation in Case |
8.94E-01 (Median) | Methylation in Control | 9.00E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 12 |
Methylation of SLC25A10 in papillary thyroid cancer | [ 9 ] | |||
Location |
Body (cg22481974) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.00E+00 | Statistic Test | p-value: 2.51E-02; Z-score: -3.41E-01 | ||
Methylation in Case |
9.24E-01 (Median) | Methylation in Control | 9.28E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Prostate cancer |
2 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC25A10 in prostate cancer | [ 10 ] | |||
Location |
TSS1500 (cg09275968) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.53E+00 | Statistic Test | p-value: 1.06E-02; Z-score: 4.89E+00 | ||
Methylation in Case |
2.27E-01 (Median) | Methylation in Control | 1.49E-01 (Median) | ||
Studied Phenotype |
Prostate cancer [ ICD-11: 2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC25A10 in prostate cancer | [ 10 ] | |||
Location |
TSS200 (cg22245858) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.09E+00 | Statistic Test | p-value: 5.00E-02; Z-score: 1.27E+00 | ||
Methylation in Case |
8.90E-01 (Median) | Methylation in Control | 8.19E-01 (Median) | ||
Studied Phenotype |
Prostate cancer [ ICD-11: 2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Systemic lupus erythematosus |
2 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC25A10 in systemic lupus erythematosus | [ 11 ] | |||
Location |
TSS1500 (cg07845392) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.02E+00 | Statistic Test | p-value: 1.86E-02; Z-score: 1.52E-01 | ||
Methylation in Case |
5.85E-01 (Median) | Methylation in Control | 5.73E-01 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus [ ICD-11: 4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC25A10 in systemic lupus erythematosus | [ 11 ] | |||
Location |
Body (cg06555404) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.02E+00 | Statistic Test | p-value: 3.95E-04; Z-score: -4.65E-01 | ||
Methylation in Case |
8.97E-01 (Median) | Methylation in Control | 9.16E-01 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus [ ICD-11: 4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Atypical teratoid rhabdoid tumor |
13 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC25A10 in atypical teratoid rhabdoid tumor | [ 12 ] | |||
Location |
1stExon (cg10299667) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.30E+00 | Statistic Test | p-value: 3.59E-20; Z-score: -3.76E+00 | ||
Methylation in Case |
6.28E-01 (Median) | Methylation in Control | 8.14E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC25A10 in atypical teratoid rhabdoid tumor | [ 12 ] | |||
Location |
Body (cg00179532) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.09E+00 | Statistic Test | p-value: 1.87E-05; Z-score: -9.62E-01 | ||
Methylation in Case |
8.24E-01 (Median) | Methylation in Control | 8.98E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC25A10 in atypical teratoid rhabdoid tumor | [ 12 ] | |||
Location |
Body (cg03372654) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -6.18E+00 | Statistic Test | p-value: 2.94E-04; Z-score: -5.98E-01 | ||
Methylation in Case |
2.35E-02 (Median) | Methylation in Control | 1.46E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC25A10 in atypical teratoid rhabdoid tumor | [ 12 ] | |||
Location |
Body (cg05485968) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.04E+00 | Statistic Test | p-value: 1.53E-03; Z-score: 1.93E-01 | ||
Methylation in Case |
1.64E-01 (Median) | Methylation in Control | 1.57E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC25A10 in atypical teratoid rhabdoid tumor | [ 12 ] | |||
Location |
Body (cg06555404) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.03E+00 | Statistic Test | p-value: 2.49E-03; Z-score: -5.81E-01 | ||
Methylation in Case |
9.25E-01 (Median) | Methylation in Control | 9.55E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC25A10 in atypical teratoid rhabdoid tumor | [ 12 ] | |||
Location |
Body (cg08120644) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.09E+00 | Statistic Test | p-value: 5.34E-03; Z-score: 2.19E-01 | ||
Methylation in Case |
8.88E-02 (Median) | Methylation in Control | 8.16E-02 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC25A10 in atypical teratoid rhabdoid tumor | [ 12 ] | |||
Location |
Body (cg09996840) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.04E+00 | Statistic Test | p-value: 1.29E-02; Z-score: 8.05E-01 | ||
Methylation in Case |
8.56E-01 (Median) | Methylation in Control | 8.23E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of SLC25A10 in atypical teratoid rhabdoid tumor | [ 12 ] | |||
Location |
Body (cg10460003) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.21E+00 | Statistic Test | p-value: 1.48E-02; Z-score: -3.87E-01 | ||
Methylation in Case |
1.35E-01 (Median) | Methylation in Control | 1.63E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 9 |
Methylation of SLC25A10 in atypical teratoid rhabdoid tumor | [ 12 ] | |||
Location |
Body (cg11609462) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.00E+00 | Statistic Test | p-value: 2.34E-02; Z-score: -3.21E-02 | ||
Methylation in Case |
1.04E-01 (Median) | Methylation in Control | 1.04E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 10 |
Methylation of SLC25A10 in atypical teratoid rhabdoid tumor | [ 12 ] | |||
Location |
Body (cg13117272) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.06E+00 | Statistic Test | p-value: 3.28E-02; Z-score: 7.11E-01 | ||
Methylation in Case |
9.06E-01 (Median) | Methylation in Control | 8.57E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 11 |
Methylation of SLC25A10 in atypical teratoid rhabdoid tumor | [ 12 ] | |||
Location |
Body (cg13150534) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.00E+00 | Statistic Test | p-value: 3.31E-02; Z-score: -2.71E-01 | ||
Methylation in Case |
9.80E-01 (Median) | Methylation in Control | 9.82E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 12 |
Methylation of SLC25A10 in atypical teratoid rhabdoid tumor | [ 12 ] | |||
Location |
3'UTR (cg06380072) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.66E+00 | Statistic Test | p-value: 1.17E-13; Z-score: 2.38E+00 | ||
Methylation in Case |
7.58E-01 (Median) | Methylation in Control | 4.56E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 13 |
Methylation of SLC25A10 in atypical teratoid rhabdoid tumor | [ 12 ] | |||
Location |
3'UTR (cg08367465) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.41E+00 | Statistic Test | p-value: 4.91E-13; Z-score: -1.91E+00 | ||
Methylation in Case |
4.61E-01 (Median) | Methylation in Control | 6.49E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Lung adenocarcinoma |
4 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC25A10 in lung adenocarcinoma | [ 13 ] | |||
Location |
Body (cg00179532) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.01E+00 | Statistic Test | p-value: 3.74E-03; Z-score: 1.79E+00 | ||
Methylation in Case |
9.71E-01 (Median) | Methylation in Control | 9.63E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC25A10 in lung adenocarcinoma | [ 13 ] | |||
Location |
Body (cg06555404) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.02E+00 | Statistic Test | p-value: 4.78E-03; Z-score: -1.32E+00 | ||
Methylation in Case |
8.80E-01 (Median) | Methylation in Control | 9.02E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC25A10 in lung adenocarcinoma | [ 13 ] | |||
Location |
Body (cg08120644) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.02E+00 | Statistic Test | p-value: 4.05E-02; Z-score: 8.71E-01 | ||
Methylation in Case |
9.17E-01 (Median) | Methylation in Control | 8.98E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC25A10 in lung adenocarcinoma | [ 13 ] | |||
Location |
3'UTR (cg06380072) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.03E+00 | Statistic Test | p-value: 9.16E-03; Z-score: -1.96E+00 | ||
Methylation in Case |
8.71E-01 (Median) | Methylation in Control | 8.95E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Panic disorder |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC25A10 in panic disorder | [ 14 ] | |||
Location |
Body (cg11609462) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.06E+00 | Statistic Test | p-value: 4.34E-02; Z-score: 1.97E-01 | ||
Methylation in Case |
2.20E+00 (Median) | Methylation in Control | 2.08E+00 (Median) | ||
Studied Phenotype |
Panic disorder [ ICD-11: 6B01] | ||||
Experimental Material |
Patient tissue samples | ||||
microRNA |
|||||
Unclear Phenotype |
4 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
miR-1 directly targets SLC25A10 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | Proteomics | ||
miRNA Stemloop ID |
miR-1 | miRNA Mature ID | miR-1-3p | ||
miRNA Sequence |
UGGAAUGUAAAGAAGUAUGUAU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human cervical cancer cell line (Hela) | ||||
Epigenetic Phenomenon 2 |
miR-193b directly targets SLC25A10 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | CLASH | ||
miRNA Stemloop ID |
miR-193b | miRNA Mature ID | miR-193b-3p | ||
miRNA Sequence |
AACUGGCCCUCAAAGUCCCGCU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon 3 |
miR-222 directly targets SLC25A10 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | CLASH | ||
miRNA Stemloop ID |
miR-222 | miRNA Mature ID | miR-222-3p | ||
miRNA Sequence |
AGCUACAUCUGGCUACUGGGU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon 4 |
miR-4726 directly targets SLC25A10 | [ 17 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-4726 | miRNA Mature ID | miR-4726-3p | ||
miRNA Sequence |
ACCCAGGUUCCCUCUGGCCGCA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.